Hitoshi Murai
Toyonaka, 5610825, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Molecular design and evaluation of aza-polycyclic carbamoyl pyridones as HIV-1 integrase strand transfer inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: April 25, 2024
Developmental competence of interspecies cloned embryos produced using cells from large Japanese field mice (Apodemus speciosus) and oocytes from laboratory mice (Mus musculus domesticus).
Journal: The Journal of reproduction and development
Published: March 28, 2020
A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity.
Journal: Bioorganic & medicinal chemistry
Published: December 23, 2014
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).
Journal: Journal of medicinal chemistry
Published: July 13, 2013
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125).
Journal: Journal of medicinal chemistry
Published: May 03, 2013
Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles.
Journal: Journal of medicinal chemistry
Published: January 16, 2013
Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore.
Journal: Journal of medicinal chemistry
Published: September 12, 2012
Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformation.
Journal: ACS medicinal chemistry letters
Published: April 07, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026